Efficacy and Safety of Oral Selinexor in Recurrent Glioblastoma
Sign in to PracticeUpdate
Only registered members have full access to PracticeUpdate content.
Additional Info
Clinical Cancer Research
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.
A Phase 2 Study of the Efficacy and Safety of Oral Selinexor in Recurrent Glioblastoma
Clin. Cancer Res 2021 Nov 02;[EPub Ahead of Print], AB Lassman, PY Wen, MJ van den Bent, SR Plotkin, AME Walenkamp, AL Green, K Li, CJ Walker, H Chang, S Tamir, L Henegar, Y Shen, MJ Alvarez, A Califano, Y Landesman, MG Kauffman, S Sacham, M Mau-SørensenFrom MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.